Natalizumab for multiple sclerosis: A complicated treatment

B. Mark Keegan

doi:10.1016/S1474-4422(11)70150-8

Natalizumab for multiple sclerosis: A complicated treatment

B. Mark Keegan

Neurology

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	677-678
Number of pages	2
Journal	The Lancet Neurology
Volume	10
Issue number	8
DOIs	https://doi.org/10.1016/S1474-4422(11)70150-8
State	Published - Aug 2011

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1016/S1474-4422(11)70150-8

Cite this

@article{cb5d14cb77434935bc082b9bfed83b17,

title = "Natalizumab for multiple sclerosis: A complicated treatment",

author = "Keegan, {B. Mark}",

year = "2011",

month = aug,

doi = "10.1016/S1474-4422(11)70150-8",

language = "English (US)",

volume = "10",

pages = "677--678",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "Lancet Publishing Group",

number = "8",

}

TY - JOUR

T1 - Natalizumab for multiple sclerosis

T2 - A complicated treatment

AU - Keegan, B. Mark

PY - 2011/8

Y1 - 2011/8

UR - http://www.scopus.com/inward/record.url?scp=79960364322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960364322&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(11)70150-8

DO - 10.1016/S1474-4422(11)70150-8

M3 - Letter

C2 - 21777819

AN - SCOPUS:79960364322

SN - 1474-4422

VL - 10

SP - 677

EP - 678

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 8

ER -

Natalizumab for multiple sclerosis: A complicated treatment

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this